CNS Therapeutics A World Market Review

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution

  • $ 3 500
  • Industry report
  • by GBI Research
  • May 2012
  • 129 pages

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution Summary GBI Research, the leading business intelligence provider, has released its latest research ?Generics in Cardiovascular Diseases ...

Industries: Pathology | Countries: World

Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential

Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential

  • $ 3 500
  • Industry report
  • by GBI Research
  • May 2012
  • 145 pages

Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential Summary GBI Research, the leading business intelligence provider, has released its latest report, ?Antibacterials Market to 2017 - Innovative Anti-Infectives that Target ...

Industries: Therapy | Countries: World

Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications

Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications

  • $ 3 500
  • Industry report
  • by GBI Research
  • May 2012
  • 140 pages

Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications Summary GBI Research's new report, ?Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease ...

Industries: Therapy | Countries: World

Pharmaceutical in United States: Ferring Pharmaceuticals, Inc. ? Product Pipeline Review - H2 2011

Pharmaceutical in United States: Ferring Pharmaceuticals, Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 38 pages

- Product Pipeline Review - H2 2011? provides a detailed overview on the Ferring Pharmaceuticals, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using ...

Industries: Pharmaceutical | Countries: World

Anavex Life Sciences Corp. - Product Pipeline Review - 2012

Anavex Life Sciences Corp. - Product Pipeline Review - 2012

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 54 pages

Anavex Life Sciences Corp. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Anavex Life Sciences Corp. - Product Pipeline Review - 2012? provides data on the Anavex Life Sciences Corp.'s research and development focus. The report includes information on current ...

Industries: Therapy | Countries: World

Drug Discovery and Development in United States: BioMarin Pharmaceutical Inc. ? Product Pipeline Review - H2 2011

Drug Discovery and Development in United States: BioMarin Pharmaceutical Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 96 pages

- Product Pipeline Review - H2 2011? provides a detailed overview on the BioMarin Pharmaceutical Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using ...

Industries: Pharmaceutical | Countries: United States, World, Ireland

Drug Discovery and Development in United States: Bionovo, Inc. ? Product Pipeline Review - H2 2011

Drug Discovery and Development in United States: Bionovo, Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 68 pages

- Product Pipeline Review - H2 2011? provides a detailed overview on the Bionovo, Inc.?s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data ...

Industries: Therapy | Countries: World

Pathology in United States: Boehringer Ingelheim GmbH - Product Pipeline Review - H2 2011

Pathology in United States: Boehringer Ingelheim GmbH - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 285 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, Boehringer Ingelheim GmbH's corporate website, SEC ...

Industries: Drug and Medication | Countries: World

Drug and Medication in United States: BTG plc - Product Pipeline Review - H2 2011

Drug and Medication in United States: BTG plc - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 120 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, BTG plc's corporate website, SEC filings, investo ...

Industries: Drug Delivery Technology | Countries: United States, World

Drug and Medication in United States: CSL Limited - Product Pipeline Review - H2 2011

Drug and Medication in United States: CSL Limited - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 104 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, CSL Limited's corporate website, SEC filings, investo ...

Industries: Therapy | Countries: United States, World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • 00 1 718 618 48 97

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.